
Buy HEP-1 (Gepon) Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.

Buy HEP-1 (Gepon) Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
HEP-1, a synthetic hepcidin-derived peptide based on the Liver-Expressed Antimicrobial Peptide 1 (LEAP-1) family, is a cysteine-rich antimicrobial peptide fragment with a molecular weight of 2789.4 g/mol. Hepcidin peptides are characterised by a high cysteine content forming multiple intramolecular disulfide bridges that create a compact, hairpin-like beta-sheet structure. The full-length mature hepcidin (hepcidin-25) consists of 25 amino acids with four disulfide bonds and eight cysteine residues, and truncated bioactive fragments including hepcidin-20 have also been characterised in the published literature. Produced via solid-phase peptide synthesis, HEP-1 is associated with ferroportin-mediated iron homeostasis and innate antimicrobial signalling pathways in preclinical research.
Hepcidin peptides occupy a central position in preclinical iron metabolism and innate immunity research. The full-length peptide was first isolated from human blood ultrafiltrate and has been characterised as the principal hormonal regulator of systemic iron homeostasis, acting through direct binding and internalisation of ferroportin, the sole known cellular iron exporter. In vitro studies have documented that hepcidin binds ferroportin and induces its internalisation and degradation, reducing cellular iron export, establishing this binding-and-internalisation mechanism as the molecular basis for hepcidin’s control of cellular iron efflux [1]. In vivo rodent studies have investigated the relationship between hepcidin peptide administration and systemic iron distribution, documenting that synthetic hepcidin produces rapid, dose-dependent hypoferremia in mice and concentrates in ferroportin-containing organs, characterising the peptide as a direct regulator of systemic iron availability in vivo [2], making HEP-1 a reference compound in iron-metabolism and innate-immunity research examining hepcidin–ferroportin regulation of cellular and systemic iron handling in preclinical models.
HEP-1 is manufactured in a cGMP compliant, ISO9001 certified laboratory to a guaranteed purity of 98% or above. Every batch is independently tested using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Editorial Team

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed and approved 14 June 2026
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Buy 5+ vials to unlock discounts
Quality Guaranteed
Every batch is HPLC-tested to ≥99% purity. Certificate of Analysis and MSDS available with every order.
